EI Earnings Insight Lab
ABBV / NYSE

Abbvie Inc

Healthcare Drug Manufacturers - Other 25 earnings pages
Company site

AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated peopl

Latest snapshot
Q 2025
Latest revenue
$61.2B
Latest EPS
$2.36
Market cap
$0
Location
North Chicago, Illinois
Recent coverage

Recent earnings pages for Abbvie Inc

See filtered archive
Q 2025 / Filed 2026-02-20

Abbvie Inc Q 2025 earnings

Revenue
$61.2B
EPS
$2.36
Revenue YoY
+8.6%
Q4 2025 / Filed 2026-02-20

Abbvie Inc Q4 2025 earnings

Revenue
$16.6B
EPS
$1.02
Revenue YoY
+10%
Q3 2025 / Filed 2025-11-04

Abbvie Inc Q3 2025 earnings

Revenue
$15.8B
EPS
$0.10
Revenue YoY
+9.1%
Q2 2025 / Filed 2025-08-04

Abbvie Inc Q2 2025 earnings

Revenue
$15.4B
EPS
$0.53
Revenue YoY
+6.6%
Q1 2025 / Filed 2025-05-09

Abbvie Inc Q1 2025 earnings

Revenue
$13.3B
EPS
$0.72
Revenue YoY
+8.4%
Q 2024 / Filed 2025-02-14

Abbvie Inc Q 2024 earnings

Revenue
$56.3B
EPS
$2.39
Revenue YoY
+3.7%
Q4 2024 / Filed 2025-02-14

Abbvie Inc Q4 2024 earnings

Revenue
$15.1B
EPS
$-0.02
Revenue YoY
+5.6%
Q3 2024 / Filed 2024-11-04

Abbvie Inc Q3 2024 earnings

Revenue
$14.5B
EPS
$0.88
Revenue YoY
+3.8%
Q2 2024 / Filed 2024-08-07

Abbvie Inc Q2 2024 earnings

Revenue
$14.5B
EPS
$0.77
Revenue YoY
+4.3%
Q1 2024 / Filed 2024-05-03

Abbvie Inc Q1 2024 earnings

Revenue
$12.3B
EPS
$0.77
Revenue YoY
+0.7%
Q4 2023 / Filed 2024-02-20

Abbvie Inc Q4 2023 earnings

Revenue
$14.3B
EPS
$0.46
Revenue YoY
-5.4%
Q 2023 / Filed 2024-02-20

Abbvie Inc Q 2023 earnings

Revenue
$54.3B
EPS
$2.72
Revenue YoY
-6.4%
0.378083s